KPF
OACC

K2 Principal Fund’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

K2 Principal Fund’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.07M Hold
195,292
– – 0.14% 170
2025
Q4 		$2.07M Hold
195,292
– – 0.17% 158
2025
Q3 		$2.05M Hold
195,292
– – 0.17% 153
2025
Q2 		$2.04M Hold
195,292
– – 0.28% 107
2025
Q1 		$2M Hold
195,292
– – 0.25% 110
2024
Q4 		$1.95M Buy
+195,292
New +$1.95M 0.22% 112

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $386M AUM 45.42% 1-Year Est. Return
FBCM
Fort Baker Capital Management Larkspur, California $1.27B AUM 25.46% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

K2 Principal Fund's OACC Position: Q1 2026 in Review

K2 Principal Fund held its Oaktree Acquisition Corp III Life Sciences (OACC) position steady in Q1 2026 at 195,292 shares worth $2.07M. The position accounts for 0.14% of the portfolio, ranked #170.

K2 Principal Fund first reported a position in OACC in Q4 2024 and has held it in 6 quarters since. 51 funds tracked by Wall St. Rank hold OACC as of Q1 2026.

  • K2 Principal Fund held 195,292 shares of Oaktree Acquisition Corp III Life Sciences worth $2.07M as of Q1 2026.
  • K2 Principal Fund left its Oaktree Acquisition Corp III Life Sciences share count unchanged in Q1 2026.
  • Oaktree Acquisition Corp III Life Sciences made up 0.14% of K2 Principal Fund's portfolio in Q1 2026, its #170 holding.
  • K2 Principal Fund first reported a position in Oaktree Acquisition Corp III Life Sciences in Q4 2024 and has held it in 6 quarters since.
  • 51 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q1 2026.

Based on K2 Principal Fund's 13F filing for Q1 2026, filed 14 May 2026.